Weissmann, Thomas ; Speer, Stefan ; Putz, Florian 
; Lettmaier, Sebastian ; Schubert, Philipp ; Shariff, Maya ; Semrau, Sabine ; Gostian, Antoniu-Oreste ; Traxdorf, Maximilian ; Mueller, Sarina K. ; Eckstein, Markus ; Hautmann, Matthias ; von der Grün, Jens ; Haderlein, Marlen ; Frey, Benjamin ; Gaipl, Udo S. ; Bert, Christoph ; Iro, Heinrich ; Fietkau, Rainer ; Hecht, Markus
Alternative Links zum Volltext:DOIVerlag
| Dokumentenart: | Artikel |
|---|
| Titel eines Journals oder einer Zeitschrift: | Journal of Clinical Medicine |
|---|
| Verlag: | MDPI |
|---|
| Ort der Veröffentlichung: | BASEL |
|---|
| Band: | 10 |
|---|
| Nummer des Zeitschriftenheftes oder des Kapitels: | 20 |
|---|
| Seitenbereich: | S. 4653 |
|---|
| Datum: | 2021 |
|---|
| Institutionen: | Medizin > Lehrstuhl für Strahlentherapie |
|---|
| Identifikationsnummer: | | Wert | Typ |
|---|
| 10.3390/jcm10204653 | DOI |
|
|---|
| Stichwörter / Keywords: | SQUAMOUS-CELL CARCINOMA; MODULATED RADIATION-THERAPY; FALSE DISCOVERY RATE; CAROTID STENOSIS; ORAL TONGUE; NCIC CTG; DELINEATION; CHEMOTHERAPY; RISK; CHEMORADIOTHERAPY; de-intensification; radiotherapy; head neck cancer; definitive treatment; volume reduction; salivary glands; swallowing function |
|---|
| Dewey-Dezimal-Klassifikation: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin |
|---|
| Status: | Veröffentlicht |
|---|
| Begutachtet: | Ja, diese Version wurde begutachtet |
|---|
| An der Universität Regensburg entstanden: | Ja |
|---|
| Dokumenten-ID: | 56501 |
|---|
Web of Science
Zusammenfassung
Definitive radiochemotherapy of locally advanced head and neck squamous cell cancer (HNSCC) achieves high locoregional tumor control rates; but is frequently associated with long-term toxicity. A future direction could be a de-escalation strategy focusing on treated volume rather than radiotherapy dose. This analysis evaluates radiotherapy dose and volume parameters of patients treated with a ...
Zusammenfassung
Definitive radiochemotherapy of locally advanced head and neck squamous cell cancer (HNSCC) achieves high locoregional tumor control rates; but is frequently associated with long-term toxicity. A future direction could be a de-escalation strategy focusing on treated volume rather than radiotherapy dose. This analysis evaluates radiotherapy dose and volume parameters of patients treated with a standard contouring approach in a clinical trial context compared with a revised volume-reduced contouring approach. In this case, 30 consecutive patients from the CheckRad-CD8 trial treated at a single study center were included in this analysis. Treatment toxicity and quality of life were assessed at the end of radiotherapy. Standard treatment plans (ST) following state of the art contouring guidelines that were used for patient treatment and volume reduced treatment plans (VRT) according to a revised simulated approach were calculated for each patient. Planning target volumes (PTV) and mean doses to 38 organs-at-risk structures were compared. At the end of radiotherapy patients reported high rates of mucositis; dysphagia and xerostomia. In addition; patient reported quality of life as assessed by the EORTC QLQ-HN35 questionnaire deteriorated. Comparing the two contouring approaches; the elective PTV_56 Gy and the high risk PTV_63 Gy (shrinking field) were significantly smaller in the VRT group. Significant reduction of mean dose to structures of the oral cavity; the larynx as well as part of the swallowing muscles and the submandibular glands was achieved in the simulated VRT-plan. Treatment de-intensification by reduction of the irradiated volume could potentially reduce treatment volume and mean doses to organs at risk. The proposed contouring approach should be studied further in the context of a clinical trial.
Altmetric